Plain-English translation of NCT05818683 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This study is testing a new drug called to see if it works better when combined with other prostate cancer medications that doctors already use. The trial is designed for men with advanced prostate cancer that has spread to other parts of the body. Researchers want to find the safest and most effective dose of this medication to use alongside standard treatments.
Men with advanced prostate cancer often develop resistance to current treatments, and their cancer continues to grow. This trial is exploring whether adding this medication to existing therapies might help slow or stop the cancer better than treatments alone.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
The trial has two parts: first, researchers will test increasing doses of the new medication combined with one of several standard prostate cancer drugs to find the safest dose; then, more participants will receive this established dose combination. You will have regular clinic visits for blood tests, imaging scans, and check-ups to monitor how the treatment is working and any side effects you experience. The trial involves about 300 participants total, and your specific involvement will depend on which treatment combination you are assigned to.
AI-generated summary from trial data ยท Aug 29, 2026 ยท Not medical advice
United States